2022•International Journal of Current Microbiology and Applied SciencesOpen access

Study on Effect of Filgrastim in Severe Leukopenia Condition in Dogs

Koppula Anusha, Basiri Dinesh, Keshamoni Ramesh, Jupaka Shashank, K. Mohanambal

Open full text 0 citations

Abstract

Filgrastim is a recombinant Methionyl Human Granulocyte- Stimulating Factor (r-metHuGCSF) analog used to stimulate the proliferation and differentiation of granulocytes in humans. Young pups and kittens suffer from severe leukopenia and neutropenia condition (etiology may be viral or bacterial or parasitic). Neutrophils being first line of defense in immunity system and decreased count may lead to increased mortality. In the present investigation 3 dogs with severe leukopenia and neutropenia condition when treated dogs with Filgrastim @ 10 μg/ kg b.wt. s.c daily for three days along with other supportive treatment, was found to be effective in correcting the hematological parameters within 48 hours of last dose of treatment and all those showed fast recovery also.

About this research paper

What this paper is about

Filgrastim is a recombinant Methionyl Human Granulocyte- Stimulating Factor (r-metHuGCSF) analog used to stimulate the proliferation and differentiation of granulocytes in humans. Young pups and kittens suffer from severe leukopenia and neutropenia condition (etiology may be viral or bacterial or parasitic). Neutrophils being first line of defense in immunity system and decreased count may lead to increased mortality. In the present investigation 3 dogs with severe leukopenia and neutropenia condition when treated dogs with Filgrastim @ 10 μg/ kg b.wt. s.c daily for three days along with other supportive treatment, was found to be effective in correcting the hematological parameters within 48 hours of last dose of treatment and all those showed fast recovery also.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Filgrastim is a recombinant Methionyl Human Granulocyte- Stimulating Factor (r-metHuGCSF) analog used to stimulate the proliferation and differentiation of granulocytes in humans. Young pups and kittens suffer from severe leukopenia and neutropenia condition (etiology may be viral or bacterial or parasitic). Neutrophils being first line of defense in immunity system and decreased count may lead to increased mortality. In the present investigation 3 dogs with severe leukopenia and neutropenia condition when treated dogs with Filgrastim @ 10 μg/ kg b.wt. s.c daily for three days along with other supportive treatment, was found to be effective in correcting the hematological parameters within 48 hours of last dose of treatment and all those showed fast recovery also.

Key concepts: Leukopenia, Filgrastim, Neutropenia, Medicine, Granulocyte, Granulocyte colony-stimulating factor, Immunology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Effect of Filgrastim in Severe Leukopenia Condition in Dogs — Research Paper | ScholarLens